Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes
Journal of Virology · 2025
DOI: 10.1128/jvi.00002-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Hao Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. Hauptthemen laut MEDLINE: SARS-CoV-2, Qa-SNARE Proteins, COVID-19, Autophagosomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Institute of Respiratory Health (GIRH).
Abstract (Originalsprache)
Despite the diminishing global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus continues to circulate and undergo mutations, posing ongoing challenges for public health. A comprehensive understanding of virus entry mechanisms is crucial for managing new epidemic strains. However, the cellular processes post-endocytosis remain largely unexplored. This study employs proximity labeling to examine proteins near ACE2 post-viral infection and identified syntaxin-6 (STX6) as a factor that inhibits SARS-CoV-2 infection by impeding the endocytic release of the virus. SARS-CoV-2 infection enhances early endosome recruitment of STX6. STX6 appears to hinder the maturation of viral particles-laden early endosomes into late endosomes, from which the virus could escape. Instead, it promotes the trafficking of the virus toward the autophagy-lysosomal degradation pathway. STX6 exhibits a broad-spectrum effect against various SARS-CoV-2 variants and several other viruses that enter via endocytosis. We report for the first time the function of STX6 as a restrictive factor in viral infection. IMPORTANCE Virus entry is the first step of the virus life cycle, and the exploitation of the endo-lysosome pathway for cellular entry by viruses has been well documented. Meanwhile, the intrinsic defense present within cells interferes with virus entry. We identified STX6 as a host restriction factor for viral entry by facilitating the virus trafficking to the autophagy-lysosomal degradation pathway. Notably, STX6 exhibits broad-spectrum antiviral activity against diverse severe acute respiratory syndrome coronavirus 2 variants and other viruses employing endocytosis for entry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Guangzhou Laboratory, Guangzhou, China.
- Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Hao Sun, Yun Wang, Xinwen Chen, Rongjuan Pei
Förderung
- National Natural Science Foundation of China
- Guangzhou Institute of Respiratory Health (GIRH)
Zitieren
APA
Sun, H., Yang, Q., Zhang, Y., Cui, S., Zhou, Z., Zhang, P., Jia, L., Zhang, M., Wang, Y., Chen, X., & Pei, R. (2025). Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes. Journal of Virology. https://doi.org/10.1128/jvi.00002-25
Vancouver
Sun H, Yang Q, Zhang Y, Cui S, Zhou Z, Zhang P, et al. Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes. Journal of Virology. 2025. doi:10.1128/jvi.00002-25
BibTeX
@article{Sun2025,
author = {Sun, Hao and Yang, Qi and Zhang, Yecheng and Cui, Saisai and Zhou, Zhe and Zhang, Peilu and Jia, Lijia and Zhang, Mingxia and Wang, Yun and Chen, Xinwen and Pei, Rongjuan},
title = {Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.00002-25}
}
EUVIMED